Acadia Healthcare Says It Faces New Federal Investigations

Acadia Healthcare Says It Faces New Federal Investigations

Shares of the company, one of the largest chains of for-profit psychiatric hospitals, were down 25 percent at one point.
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices

F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.